Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burk Jubelt

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Current Neurology and Neuroscience Reports|August 29, 2012
Infectious myelitisCornelia Mihai, Burk Jubelt
Handbook of Clinical Neurology|July 13, 2014
Enterovirus/picornavirus infectionsBurk Jubelt, Howard L Lipton
Current Neurology and Neuroscience Reports|October 13, 2009
Neurologic manifestations of varicella zoster virus infectionsCatherine Amlie-Lefond, Burk Jubelt
Neurology|April 28, 2004
ALS: persistent scientists do not find persisting enterovirusesBurk Jubelt, Howard L Lipton
Current Neurology and Neuroscience Reports|September 30, 2011
Rhombencephalitis / brainstem encephalitisBurk Jubelt, Cornelia Mihai, Terrence M Li, et al.
Microbial Pathogenesis|September 11, 2002
The neuropathology observed in wild-type mice inoculated with human poliovirus mirrors human paralytic poliomyelitisDayton J Ford, Stacie L Ropka, George H Collins, et al.
Clinical Immunology (Orlando, Fla.)|December 23, 2011
Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patientsGeorge P Christophi, Ross C Gruber, Michael Panos, et al.
Clinical Imaging|July 26, 2002
Magnetic resonance imaging of mesenrhombencephalitisJohn J Wasenko, Brian J Park, Burk Jubelt, et al.
Journal of the Neurological Sciences|June 11, 2011
Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patientsGeorge P Christophi, Jennifer A Christophi, Ross C Gruber, et al.
Clinical Immunology (Orlando, Fla.)|June 30, 2009
Interferon-beta treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1George P Christophi, Michael Panos, Chad A Hudson, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Current Neurology and Neuroscience Reports|August 29, 2012
Infectious myelitisCornelia Mihai, Burk Jubelt
Handbook of Clinical Neurology|July 13, 2014
Enterovirus/picornavirus infectionsBurk Jubelt, Howard L Lipton
Current Neurology and Neuroscience Reports|October 13, 2009
Neurologic manifestations of varicella zoster virus infectionsCatherine Amlie-Lefond, Burk Jubelt
Neurology|April 28, 2004
ALS: persistent scientists do not find persisting enterovirusesBurk Jubelt, Howard L Lipton
Current Neurology and Neuroscience Reports|September 30, 2011
Rhombencephalitis / brainstem encephalitisBurk Jubelt, Cornelia Mihai, Terrence M Li, et al.
Microbial Pathogenesis|September 11, 2002
The neuropathology observed in wild-type mice inoculated with human poliovirus mirrors human paralytic poliomyelitisDayton J Ford, Stacie L Ropka, George H Collins, et al.
Clinical Immunology (Orlando, Fla.)|December 23, 2011
Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patientsGeorge P Christophi, Ross C Gruber, Michael Panos, et al.
Clinical Imaging|July 26, 2002
Magnetic resonance imaging of mesenrhombencephalitisJohn J Wasenko, Brian J Park, Burk Jubelt, et al.
Journal of the Neurological Sciences|June 11, 2011
Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patientsGeorge P Christophi, Jennifer A Christophi, Ross C Gruber, et al.
Clinical Immunology (Orlando, Fla.)|June 30, 2009
Interferon-beta treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1George P Christophi, Michael Panos, Chad A Hudson, et al.
Pageof 3